Literature DB >> 11940572

ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner.

Zhiyong Ren1, Timothy S Schaefer.   

Abstract

Stats (signal transducer and activator of transcription) are latent transcription factors that translocate from the cytoplasm to the nucleus. Constitutive activation of Stat3 alpha by upstream oncoproteins and receptor tyrosine kinases has been found in many human tumors and tumor-derived cell lines. Constitutively activated Stat3 alpha is often correlated with the activation of ErbB-2, a member of the EGFR family. To explore the involvement of ErbB-2 in the activation of Stat3 and the mechanism underlying this event, an ErbB-2 point mutant was used as a model of constitutively activated receptor. Phenylalanine mutations (Y-->F) were made in the autophosphorylation sites of the receptor, and their ability to activate Stat3 alpha was evaluated. Our results suggest that Stat3 alpha and JAK2 associates with ErbB-2 prior to phosphorylation of the receptor and that full activation of Stat3 alpha by ErbB-2 requires the participation of other non-receptor tyrosine kinases. Both Src and Jak2 kinases contribute to the activation of Stat3 alpha but Src binds to ErbB-2 only when the receptor is phosphorylated. Our results also suggest that tyrosine 1139 may be important for Src homology 2 domain association because a mutant lacking this tyrosine reduces the ability of the Src homology 2 domain to bind to ErbB-2 and significantly decreases its ability to activate Stat3 alpha.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11940572     DOI: 10.1074/jbc.M112438200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells.

Authors:  Valerie S Hawthorne; Wen-Chien Huang; Christopher L Neal; Ling-Min Tseng; Mien-Chie Hung; Dihua Yu
Journal:  Mol Cancer Res       Date:  2009-04       Impact factor: 5.852

2.  Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification.

Authors:  Anna A Dudka; Steve M M Sweet; John K Heath
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

3.  Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.

Authors:  Cecilia Proietti; Mariana Salatino; Cinthia Rosemblit; Romina Carnevale; Adalí Pecci; Alberto R Kornblihtt; Alfredo A Molinolo; Isabel Frahm; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

4.  Janus Kinase 1 Plays a Critical Role in Mammary Cancer Progression.

Authors:  Barbara L Wehde; Patrick D Rädler; Hridaya Shrestha; Stevi J Johnson; Aleata A Triplett; Kay-Uwe Wagner
Journal:  Cell Rep       Date:  2018-11-20       Impact factor: 9.423

5.  Phosphoproteomic analysis of Her2/neu signaling and inhibition.

Authors:  Ron Bose; Henrik Molina; A Scott Patterson; John K Bitok; Balamurugan Periaswamy; Joel S Bader; Akhilesh Pandey; Philip A Cole
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

Review 6.  Signaling cross-talk in the resistance to HER family receptor targeted therapy.

Authors:  H Yamaguchi; S-S Chang; J L Hsu; M-C Hung
Journal:  Oncogene       Date:  2013-04-01       Impact factor: 9.867

Review 7.  The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.

Authors:  Danupon Nantajit; Dong Lin; Jian Jian Li
Journal:  J Cancer Res Clin Oncol       Date:  2014-10-01       Impact factor: 4.553

8.  HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.

Authors:  Nadire Duru; Ming Fan; Demet Candas; Cheikh Menaa; Hsin-Chen Liu; Danupon Nantajit; Yunfei Wen; Kai Xiao; Angela Eldridge; Brett A Chromy; Shiyong Li; Douglas R Spitz; Kit S Lam; Max S Wicha; Jian Jian Li
Journal:  Clin Cancer Res       Date:  2012-10-22       Impact factor: 12.531

Review 9.  The HER family and cancer: emerging molecular mechanisms and therapeutic targets.

Authors:  Natalia V Sergina; Mark M Moasser
Journal:  Trends Mol Med       Date:  2007-11-05       Impact factor: 11.951

10.  Identification of a Stat3-dependent transcription regulatory network involved in metastatic progression.

Authors:  Jill J Ranger; David E Levy; Solmaz Shahalizadeh; Michael Hallett; William J Muller
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.